Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of GBP411 in Healthy Infants
TCTR20170109002Phase 2Not yet recruiting
- Sponsor
- SK Chemicals
- Start
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 12-valent pneumococcal conjugate vaccine, sponsored by SK Chemicals. Planned start Apr 2017; status: not yet recruiting.
02
Drugs
12-valent pneumococcal conjugate vaccine
Beyond the preview
Go deeper on TCTR20170109002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170109002.